Prostemics Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 0.31%

Prostemics Co. Ltd (203690) has an Asset Resilience Ratio of 0.31% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩132.50 Million

≈ $89.79K USD Cash + Short-term Investments

Total Assets

₩42.45 Billion

≈ $28.77 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Prostemics Co. Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Prostemics Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Prostemics Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 203690 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩132.50 Million	0.31%
Total Liquid Assets	₩132.50 Million	0.31%

Asset Resilience Insights

Limited Liquidity: Prostemics Co. Ltd maintains only 0.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Prostemics Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Prostemics Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.11%
89bio Inc NASDAQ:ETNB	Biotechnology	71.60%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.00%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	34.30%
Savara Inc NASDAQ:SVRA	Biotechnology	79.91%

Annual Asset Resilience Ratio for Prostemics Co. Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Prostemics Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.31%	₩132.50 Million ≈ $89.79K	₩42.45 Billion ≈ $28.77 Million	-14.70pp
2024-12-31	15.01%	₩9.16 Billion ≈ $6.21 Million	₩61.05 Billion ≈ $41.37 Million	-10.90pp
2023-12-31	25.91%	₩20.00 Billion ≈ $13.55 Million	₩77.19 Billion ≈ $52.31 Million	+19.82pp
2022-12-31	6.09%	₩3.14 Billion ≈ $2.13 Million	₩51.48 Billion ≈ $34.89 Million	-5.69pp
2021-12-31	11.78%	₩6.26 Billion ≈ $4.24 Million	₩53.16 Billion ≈ $36.03 Million	-15.40pp
2020-12-31	27.18%	₩16.36 Billion ≈ $11.09 Million	₩60.18 Billion ≈ $40.78 Million	-13.63pp
2019-12-31	40.81%	₩12.99 Billion ≈ $8.81 Million	₩31.84 Billion ≈ $21.58 Million	+9.51pp
2018-12-31	31.30%	₩10.43 Billion ≈ $7.07 Million	₩33.31 Billion ≈ $22.58 Million	+3.40pp
2017-12-31	27.90%	₩11.32 Billion ≈ $7.67 Million	₩40.58 Billion ≈ $27.50 Million	-25.38pp
2016-12-31	53.28%	₩25.07 Billion ≈ $16.99 Million	₩47.06 Billion ≈ $31.89 Million	+49.81pp
2015-12-31	3.47%	₩1.50 Billion ≈ $1.02 Million	₩43.28 Billion ≈ $29.33 Million	--

pp = percentage points

About Prostemics Co. Ltd

KQ:203690 Korea Biotechnology

Market Cap

$1.88 Million

₩2.78 Billion KRW

Market Cap Rank

#30084 Global

#2100 in Korea

Share Price

₩139.00

Change (1 day)

+0.00%

52-Week Range

₩139.00 - ₩139.00

All Time High

₩77250.00